Misfit, Inc.
USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2016–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Misfit ranks #48,788 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.
- #48,788
- of 49,997 US assignees by volume
- 3rd percentile
- by Innovation Score (14.8/100)
- 4.2
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R48788 · US Corporation #48,788 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #48,788/49,997
- PHOTO-FINISH Mipox
- CPC-NARROW A61B · 3 areas
- INNOV-LOW 14.8/100
- CLAIMS-SPARSE 4.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Mipox Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Misfit’s 14.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Misfit
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Misfit · this assignee 15
Misfit · this assignee
15 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Misfit's Innovation Score is 14.8/100 (3rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Misfit?
Each dot is one of Misfit’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Misfit’s own 4.2 claims/patent is at or below the 13.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Misfit's grants concentrate
Misfit, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 20% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2017. By volume, Misfit sits between Mipox Corporation and Mobi, LLC.
Who files at Misfit's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Mipox
Mipox Corporation
5 patents
- Miraculum
Miraculum, Inc.
5 patents
- Mircon Technology
Mircon Technology, Inc.
5 patents
- Mironid
Mironid Limited
5 patents
- Mitokinin
Mitokinin, Inc.
5 patents
- Mitsubishi Chemic…
Mitsubishi Chemical Cleansui Corporation
5 patents
- Momelan
MoMelan Technologies, Inc.
5 patents
- Mobi
Mobi, LLC
5 patents
- Misfit ◀
Misfit, Inc.
5 patents
What this shows Misfit holds 5 patents at rank #48,878, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Misfit
By rank, the assignees closest to #48,878 in granted patent volume.
- Mipox Corporation #48,874 · 5 patents
- Miraculum, Inc. #48,875 · 5 patents
- Mircon Technology, Inc. #48,876 · 5 patents
- Mironid Limited #48,877 · 5 patents
- Mitokinin, Inc. #48,879 · 5 patents
- Mitsubishi Chemical Cleansui Corporation #48,880 · 5 patents
- MoMelan Technologies, Inc. #48,881 · 5 patents
- Mobi, LLC #48,882 · 5 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Misfit's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Misfit's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
15 3rd percentile higher than 3% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 4 | 80.0% |
| 2017 | 1 | 20.0% |
Which technologies does Misfit, Inc. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Misfit, Inc.'s patent record in context - here's where to go next.
- Misfit, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 20% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #48,788 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Misfit, Inc. against Mipox Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 14.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.